Asset Management One
SAGE

Asset Management One’s Sage Therapeutics SAGE Stock Holding History

Asset Management One’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,845
Closed -$138K – 1071
2021
Q1 		$138K Buy
+1,845
New +$151K ﹤0.01% 975
2020
Q2 		– Sell
-7,218
Closed -$207K – 1078
2020
Q1 		$207K Hold
7,218
– – ﹤0.01% 952
2019
Q4 		$521K Hold
7,218
– – ﹤0.01% 938
2019
Q3 		$1.01M Buy
7,218
+4,096
+131% +$685K ﹤0.01% 870
2019
Q2 		$572K Buy
+3,122
New +$533K ﹤0.01% 949

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Asset Management One's SAGE Position: Q2 2021 in Review

Asset Management One sold out of Sage Therapeutics (SAGE) in Q2 2021, closing a stake of 1,845 shares — an estimated $138K sold.

Asset Management One first reported a position in SAGE in Q2 2019 and held it in 5 quarters. The position peaked at $1.01M in Q3 2019. 257 funds tracked by Wall St. Rank hold SAGE as of Q2 2021.

  • Asset Management One reported no remaining Sage Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Asset Management One sold 1,845 Sage Therapeutics shares in Q2 2021, an estimated $138K.
  • Asset Management One first reported a position in Sage Therapeutics in Q2 2019 and held it in 5 quarters.
  • Asset Management One's Sage Therapeutics position peaked at $1.01M in Q3 2019.
  • 257 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2021.

Based on Asset Management One's 13F filing for Q2 2021, filed 3 Aug 2021.